Graduates of the Stem Cell Biology Master's program have gone on to procure jobs in biotech industry and academic labs, and to pursue further graduate studies in PhD, MD, Vet Med and Law. Some of our graduates are featured below.
Anala Shetty joined the Stem Cell Biology Master's Program in the Fall of 2019. She is currently working with Principal Investigator Walter Low, PhD. Her research topic is "Using spacial genomics to look into the transcriptome and proteome during blastocyst complementation". But being a student involves more than hitting the books. Anala is also a yoga flow instructor at the UMN RecWell Center who now misses practicing yoga with a group. However, she created a simple yoga flow on the RecWell YouTube page for people to follow along during this time when gathering is restricted.
Anala says that "Yoga has tremendously helped me during this pandemic to feel good mentally and physically. Regularly practicing the yoga asanas followed by meditation leaves me feeling calm, re-energized and grateful for the good things in life. It has helped me cope with the reality of the situation during this unprecedented time with a positive mindset and make everyday count."
We applaud her contribution to wellness among the entire University Community during this pandemic.
Henry came to our program after completing his BS in Biochemistry at the University of Minnesota in 2014, and while he was employed in the laboratory of Angela Panoskaltsis-Mortari, a member of the Stem Cell Biology graduate faculty. Henry's research project and thesis were entitled "Facilitation of Human Induced Pluripotent Stem (iPS) Cell Differentiation to Endoderm with a Novel Histone Deacetylase (HDAC) Inhibitor". After working at the Antibody Applications Quality Control Department of Bio-Techne for 2 years, Henry matriculated into the University of Minnesota Medical School in 2018.
Madison obtained her BS in Genetics & Cell Development from the College of Biological Sciences at the University of Minnesota in 2017, and worked at the University of Minnesota Genomics Center before matriculating into the SCB MS program in Fall 2017. Madison's thesis entitled "Production of induced regulatory T-cells through CRISPR/Cas9 based gene editing" was nominated for the Best MS thesis by the SCB graduate program. After obtaining her MS degree, Madison continued her research in the laboratory of her thesis advisor, Mark Osborn, and will enter the MD/PhD program at the Stritch School of Medicine at Loyola University Chicago in July 2020. Madison was a co-author of the paper "CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression" published in 2018.